CN Stock MarketDetailed Quotes

Gansu Longshenrongfa Pharmaceutical Industry (300534)

Watchlist
  • 9.39
  • -0.21-2.19%
Market Closed Apr 17 15:00 CST
2.85BMarket Cap64.76P/E (TTM)

Gansu Longshenrongfa Pharmaceutical Industry (300534) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
-14.92%886.96M
-16.12%647.29M
-8.21%496.23M
13.52%289.44M
-3.48%1.04B
-5.00%771.71M
-8.60%540.61M
-13.96%254.96M
35.06%1.08B
102.52%812.31M
Operating revenue
-14.92%886.96M
-16.12%647.29M
-8.21%496.23M
13.52%289.44M
-3.48%1.04B
-5.00%771.71M
-8.60%540.61M
-13.96%254.96M
35.06%1.08B
102.52%812.31M
Other operating revenue
45.83%21.7M
----
19.43%10.01M
----
15.41%14.88M
----
25.68%8.38M
----
12.90%12.89M
----
Total operating cost
-16.66%791M
-16.42%590.3M
-9.91%439.37M
11.78%247.3M
-3.73%949.18M
-3.56%706.28M
-8.07%487.72M
-15.45%221.23M
33.24%986M
91.91%732.33M
Operating cost
-3.38%281.43M
11.53%218.37M
31.58%167.75M
58.03%105.97M
-24.58%291.28M
-26.87%195.79M
-34.39%127.49M
-34.55%67.06M
13.10%386.23M
47.10%267.74M
Operating tax surcharges
2.11%15.39M
12.19%11.81M
25.00%9.43M
7.05%3.76M
22.18%15.08M
10.89%10.53M
4.74%7.54M
4.49%3.52M
26.17%12.34M
69.97%9.49M
Operating expense
-25.97%412.84M
-32.88%302.36M
-29.92%223.79M
-12.05%118.9M
9.77%557.67M
11.48%450.5M
8.75%319.35M
-2.47%135.19M
60.63%508.03M
162.72%404.1M
Administration expense
-8.32%55.26M
16.95%38.55M
15.76%25.59M
25.03%13.36M
15.14%60.27M
0.19%32.96M
-3.78%22.11M
-16.05%10.69M
8.50%52.35M
27.31%32.9M
Financial expense
66.70%-1.08M
57.15%-1.12M
27.55%-1.03M
-75.00%-693.76K
-4.27%-3.24M
-1.94%-2.61M
27.40%-1.42M
67.75%-396.44K
-8.25%-3.11M
-33.24%-2.56M
-Interest expense (Financial expense)
-20.38%2.66M
-22.72%1.99M
-38.58%1.29M
-38.18%673.96K
-15.27%3.34M
-9.96%2.58M
18.32%2.1M
57.64%1.09M
697.46%3.95M
477.96%2.86M
-Interest Income (Financial expense)
41.94%-3.94M
39.68%-3.2M
33.26%-2.39M
6.88%-1.4M
5.23%-6.79M
2.84%-5.3M
4.64%-3.58M
22.17%-1.5M
-111.71%-7.17M
-125.37%-5.45M
Research and development
-3.48%27.15M
6.45%20.33M
9.41%13.84M
15.86%6M
-6.77%28.13M
-7.53%19.1M
-11.79%12.65M
-9.43%5.18M
11.26%30.17M
27.03%20.65M
Credit Impairment Loss
-409.74%-7.17M
-5,407.40%-2.17M
-997.50%-3.68M
--11.15K
126.33%2.31M
100.46%40.8K
96.25%-335.51K
----
-56.67%-8.79M
-862.84%-8.96M
Asset Impairment Loss
-1,830.99%-1.77M
--45.9K
--45.9K
----
55.74%-91.44K
----
----
----
-130.83%-206.6K
----
Other net revenue
-75.64%2.54M
-31.62%5.39M
-76.94%1.29M
15.85%3.21M
804.78%10.43M
246.90%7.89M
182.72%5.61M
314.22%2.77M
-56.47%1.15M
-205.94%-5.37M
Fair value change income
99.92%-167.01
----
----
----
---208.98K
----
----
----
----
----
Invest income
33.33%800K
33.33%800K
----
----
--600K
--600K
--600K
----
----
----
Asset deal income
98.14%-12.92K
98.14%-12.92K
---12.92K
----
-194.21%-693.13K
---693.13K
----
----
---235.59K
----
Other revenue
25.55%10.69M
-15.29%6.72M
-7.56%4.94M
15.45%3.2M
-18.03%8.51M
121.15%7.94M
146.09%5.35M
314.22%2.77M
39.65%10.38M
19.87%3.59M
Operating profit
-5.07%98.5M
-14.92%62.38M
-0.59%58.16M
24.26%45.35M
8.98%103.75M
-1.73%73.32M
7.98%58.5M
3.28%36.5M
52.78%95.2M
203.53%74.61M
Add:Non operating Income
-38.22%495.67K
3,998.85%8.46M
3,980.04%8.38M
14,026.09%8.38M
-82.01%802.32K
86.64%206.28K
884.12%205.45K
3,478.96%59.34K
-24.29%4.46M
-73.71%110.53K
Less:Non operating expense
537.99%17.85M
614.23%17.61M
578.03%16.53M
189,957.10%15.49M
6.01%2.8M
470.02%2.47M
678.64%2.44M
-66.28%8.15K
28.11%2.64M
-62.38%432.5K
Total profit
-20.26%81.15M
-25.09%53.23M
-11.12%50.01M
4.64%38.24M
4.88%101.76M
-4.35%71.06M
4.42%56.27M
3.49%36.55M
46.69%97.02M
211.46%74.29M
Less:Income tax cost
-69.46%15.78M
-54.06%10.65M
-51.73%9.06M
-5.83%5.37M
292.44%51.68M
104.10%23.18M
123.48%18.77M
-5.34%5.7M
-24.70%13.17M
136.82%11.36M
Net profit
30.52%65.36M
-11.07%42.58M
9.22%40.95M
6.57%32.88M
-40.27%50.08M
-23.92%47.88M
-17.57%37.49M
5.31%30.85M
72.34%83.85M
230.24%62.93M
Net profit from continuing operation
30.52%65.36M
-11.07%42.58M
9.22%40.95M
6.57%32.88M
-40.27%50.08M
-23.92%47.88M
-17.57%37.49M
5.31%30.85M
72.34%83.85M
230.24%62.93M
Less:Minority Profit
-16.37%21.41M
-32.03%15.55M
-16.51%12.99M
-0.11%8.67M
15.32%25.6M
42.07%22.88M
17.11%15.56M
-6.60%8.68M
124.99%22.2M
430.69%16.11M
Net profit of parent company owners
79.56%43.95M
8.11%27.03M
27.48%27.96M
9.18%24.21M
-60.30%24.48M
-46.61%25M
-31.88%21.93M
10.84%22.17M
58.95%61.65M
192.27%46.83M
Earning per share
Basic earning per share
79.55%0.1449
8.13%0.0891
27.52%0.0922
9.17%0.0798
-60.29%0.0807
-46.63%0.0824
-31.86%0.0723
10.93%0.0731
58.87%0.2032
192.42%0.1544
Diluted earning per share
79.55%0.1449
8.13%0.0891
27.52%0.0922
9.17%0.0798
-60.29%0.0807
-46.63%0.0824
-31.86%0.0723
10.93%0.0731
58.87%0.2032
192.42%0.1544
Other composite income
152.90%1.18M
-2.24M
Other composite income of parent company owners
152.90%1.18M
----
----
----
---2.24M
----
----
----
----
----
Total composite income
39.10%66.55M
-11.07%42.58M
9.22%40.95M
6.57%32.88M
-42.94%47.84M
-23.92%47.88M
-17.57%37.49M
5.31%30.85M
72.34%83.85M
230.24%62.93M
Total composite income of parent company owners
102.95%45.13M
8.11%27.03M
27.48%27.96M
9.18%24.21M
-63.93%22.24M
-46.61%25M
-31.88%21.93M
10.84%22.17M
58.95%61.65M
192.27%46.83M
Total composite income of minority owners
-16.37%21.41M
-32.03%15.55M
-16.51%12.99M
-0.11%8.67M
15.32%25.6M
42.07%22.88M
17.11%15.56M
-6.60%8.68M
124.99%22.2M
430.69%16.11M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue -14.92%886.96M-16.12%647.29M-8.21%496.23M13.52%289.44M-3.48%1.04B-5.00%771.71M-8.60%540.61M-13.96%254.96M35.06%1.08B102.52%812.31M
Operating revenue -14.92%886.96M-16.12%647.29M-8.21%496.23M13.52%289.44M-3.48%1.04B-5.00%771.71M-8.60%540.61M-13.96%254.96M35.06%1.08B102.52%812.31M
Other operating revenue 45.83%21.7M----19.43%10.01M----15.41%14.88M----25.68%8.38M----12.90%12.89M----
Total operating cost -16.66%791M-16.42%590.3M-9.91%439.37M11.78%247.3M-3.73%949.18M-3.56%706.28M-8.07%487.72M-15.45%221.23M33.24%986M91.91%732.33M
Operating cost -3.38%281.43M11.53%218.37M31.58%167.75M58.03%105.97M-24.58%291.28M-26.87%195.79M-34.39%127.49M-34.55%67.06M13.10%386.23M47.10%267.74M
Operating tax surcharges 2.11%15.39M12.19%11.81M25.00%9.43M7.05%3.76M22.18%15.08M10.89%10.53M4.74%7.54M4.49%3.52M26.17%12.34M69.97%9.49M
Operating expense -25.97%412.84M-32.88%302.36M-29.92%223.79M-12.05%118.9M9.77%557.67M11.48%450.5M8.75%319.35M-2.47%135.19M60.63%508.03M162.72%404.1M
Administration expense -8.32%55.26M16.95%38.55M15.76%25.59M25.03%13.36M15.14%60.27M0.19%32.96M-3.78%22.11M-16.05%10.69M8.50%52.35M27.31%32.9M
Financial expense 66.70%-1.08M57.15%-1.12M27.55%-1.03M-75.00%-693.76K-4.27%-3.24M-1.94%-2.61M27.40%-1.42M67.75%-396.44K-8.25%-3.11M-33.24%-2.56M
-Interest expense (Financial expense) -20.38%2.66M-22.72%1.99M-38.58%1.29M-38.18%673.96K-15.27%3.34M-9.96%2.58M18.32%2.1M57.64%1.09M697.46%3.95M477.96%2.86M
-Interest Income (Financial expense) 41.94%-3.94M39.68%-3.2M33.26%-2.39M6.88%-1.4M5.23%-6.79M2.84%-5.3M4.64%-3.58M22.17%-1.5M-111.71%-7.17M-125.37%-5.45M
Research and development -3.48%27.15M6.45%20.33M9.41%13.84M15.86%6M-6.77%28.13M-7.53%19.1M-11.79%12.65M-9.43%5.18M11.26%30.17M27.03%20.65M
Credit Impairment Loss -409.74%-7.17M-5,407.40%-2.17M-997.50%-3.68M--11.15K126.33%2.31M100.46%40.8K96.25%-335.51K-----56.67%-8.79M-862.84%-8.96M
Asset Impairment Loss -1,830.99%-1.77M--45.9K--45.9K----55.74%-91.44K-------------130.83%-206.6K----
Other net revenue -75.64%2.54M-31.62%5.39M-76.94%1.29M15.85%3.21M804.78%10.43M246.90%7.89M182.72%5.61M314.22%2.77M-56.47%1.15M-205.94%-5.37M
Fair value change income 99.92%-167.01---------------208.98K--------------------
Invest income 33.33%800K33.33%800K----------600K--600K--600K------------
Asset deal income 98.14%-12.92K98.14%-12.92K---12.92K-----194.21%-693.13K---693.13K-----------235.59K----
Other revenue 25.55%10.69M-15.29%6.72M-7.56%4.94M15.45%3.2M-18.03%8.51M121.15%7.94M146.09%5.35M314.22%2.77M39.65%10.38M19.87%3.59M
Operating profit -5.07%98.5M-14.92%62.38M-0.59%58.16M24.26%45.35M8.98%103.75M-1.73%73.32M7.98%58.5M3.28%36.5M52.78%95.2M203.53%74.61M
Add:Non operating Income -38.22%495.67K3,998.85%8.46M3,980.04%8.38M14,026.09%8.38M-82.01%802.32K86.64%206.28K884.12%205.45K3,478.96%59.34K-24.29%4.46M-73.71%110.53K
Less:Non operating expense 537.99%17.85M614.23%17.61M578.03%16.53M189,957.10%15.49M6.01%2.8M470.02%2.47M678.64%2.44M-66.28%8.15K28.11%2.64M-62.38%432.5K
Total profit -20.26%81.15M-25.09%53.23M-11.12%50.01M4.64%38.24M4.88%101.76M-4.35%71.06M4.42%56.27M3.49%36.55M46.69%97.02M211.46%74.29M
Less:Income tax cost -69.46%15.78M-54.06%10.65M-51.73%9.06M-5.83%5.37M292.44%51.68M104.10%23.18M123.48%18.77M-5.34%5.7M-24.70%13.17M136.82%11.36M
Net profit 30.52%65.36M-11.07%42.58M9.22%40.95M6.57%32.88M-40.27%50.08M-23.92%47.88M-17.57%37.49M5.31%30.85M72.34%83.85M230.24%62.93M
Net profit from continuing operation 30.52%65.36M-11.07%42.58M9.22%40.95M6.57%32.88M-40.27%50.08M-23.92%47.88M-17.57%37.49M5.31%30.85M72.34%83.85M230.24%62.93M
Less:Minority Profit -16.37%21.41M-32.03%15.55M-16.51%12.99M-0.11%8.67M15.32%25.6M42.07%22.88M17.11%15.56M-6.60%8.68M124.99%22.2M430.69%16.11M
Net profit of parent company owners 79.56%43.95M8.11%27.03M27.48%27.96M9.18%24.21M-60.30%24.48M-46.61%25M-31.88%21.93M10.84%22.17M58.95%61.65M192.27%46.83M
Earning per share
Basic earning per share 79.55%0.14498.13%0.089127.52%0.09229.17%0.0798-60.29%0.0807-46.63%0.0824-31.86%0.072310.93%0.073158.87%0.2032192.42%0.1544
Diluted earning per share 79.55%0.14498.13%0.089127.52%0.09229.17%0.0798-60.29%0.0807-46.63%0.0824-31.86%0.072310.93%0.073158.87%0.2032192.42%0.1544
Other composite income 152.90%1.18M-2.24M
Other composite income of parent company owners 152.90%1.18M---------------2.24M--------------------
Total composite income 39.10%66.55M-11.07%42.58M9.22%40.95M6.57%32.88M-42.94%47.84M-23.92%47.88M-17.57%37.49M5.31%30.85M72.34%83.85M230.24%62.93M
Total composite income of parent company owners 102.95%45.13M8.11%27.03M27.48%27.96M9.18%24.21M-63.93%22.24M-46.61%25M-31.88%21.93M10.84%22.17M58.95%61.65M192.27%46.83M
Total composite income of minority owners -16.37%21.41M-32.03%15.55M-16.51%12.99M-0.11%8.67M15.32%25.6M42.07%22.88M17.11%15.56M-6.60%8.68M124.99%22.2M430.69%16.11M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More